Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes
- 1 September 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (17) , 1323-1332
- https://doi.org/10.1038/sj.gt.3301529
Abstract
This study compared a range of mammalian CNS expression cassettes in recombinant adeno-associated virus (AAV-2) vectors using strong endogenous promoter sequences, with or without a strong post-regulatory element and polyadenylation signal. Changes in these elements led to transgene expression varying by over three orders of magnitude. In experiments conducted in primary cell culture and in >100 stereotactically injected rats, we observed highly efficient and stable (>15 months) gene expression in neurons and limited expression in glia; the highest expression occurred with endogenous, nonviral promoters such as neuron-specific enolase and beta-actin. The packaging size of AAV-2 was maximized at 5.7 kb without impairing gene expression, as judged by direct comparison with a number of smaller AAV-2 constructs. The genomic insert size and titer were confirmed by Southern blot and quantitative PCR, and infectivity was tested by particle titer using ELISA with a conformation-dependent epitope that requires the full intact capsid. A packaging and purification protocol we describe allows for high-titer, high-capacity AAV-2 vectors that can transduce over 2 x 10(5) neurons in vivo per microliter of vector, using the strongest expression cassette.Keywords
This publication has 46 references indexed in Scilit:
- Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Modification of an Adenoviral Vector with Biologically Selected Peptides: A Novel Strategy for Gene Delivery to Cells of ChoiceHuman Gene Therapy, 1999
- Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2Nature Medicine, 1999
- A system for the propagation of adenoviral vectors with genetically modified receptor specificitiesNature Biotechnology, 1999
- Peroral gene therapy of lactose intolerance using an adeno-associated virus vectorNature Medicine, 1998
- In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vectorGene Therapy, 1998
- Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vectorBrain Research, 1996
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoterCellular and Molecular Neurobiology, 1993
- Gene Transfer into Mammalian Central Nervous System Using Herpes Virus Vectors: Extended Expression of Bacterial lacZ in Neurons Using the Neuron-Specific Enolase PromoterHuman Gene Therapy, 1992